Logo image of PACX

PIONEER MERGER CORP -CLASS A (PACX) Stock Fundamental Analysis

NASDAQ:PACX - Nasdaq - KYG7S24C1034 - Common Stock - Currency: USD

10.2  0 (0%)

After market: 10.19 -0.01 (-0.1%)

Fundamental Rating

2

Taking everything into account, PACX scores 2 out of 10 in our fundamental rating. PACX was compared to 0 industry peers in the Unkown industry. The financial health of PACX is average, but there are quite some concerns on its profitability. PACX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PACX was profitable.
PACX had a positive operating cash flow in the past year.
PACX Yearly Net Income VS EBIT VS OCF VS FCFPACX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 5M -5M

1.2 Ratios

Industry RankSector Rank
ROA 9.84%
ROE 10.22%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PACX Yearly ROA, ROE, ROICPACX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 100 200 300

1.3 Margins

PACX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PACX Yearly Profit, Operating, Gross MarginsPACX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

6

2. Health

2.1 Basic Checks

PACX has more shares outstanding than it did 1 year ago.
PACX has a better debt/assets ratio than last year.
PACX Yearly Shares OutstandingPACX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M 40M 50M
PACX Yearly Total Debt VS Total AssetsPACX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 19.58 indicates that PACX is not in any danger for bankruptcy at the moment.
There is no outstanding debt for PACX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 19.58
ROIC/WACCN/A
WACCN/A
PACX Yearly LT Debt VS Equity VS FCFPACX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 14.79 indicates that PACX has no problem at all paying its short term obligations.
A Quick Ratio of 14.79 indicates that PACX has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 14.79
Quick Ratio 14.79
PACX Yearly Current Assets VS Current LiabilitesPACX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

PACX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18482.72%, which is quite impressive.
EPS 1Y (TTM)18482.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PACX Yearly Revenue VS EstimatesPACX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021
PACX Yearly EPS VS EstimatesPACX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.91, which indicates a correct valuation of PACX.
PACX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
Industry RankSector Rank
PE 12.91
Fwd PE N/A
PACX Price Earnings VS Forward Price EarningsPACX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 41.07
EV/EBITDA N/A
PACX Per share dataPACX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PACX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PIONEER MERGER CORP -CLASS A

NASDAQ:PACX (1/12/2023, 8:00:04 PM)

After market: 10.19 -0.01 (-0.1%)

10.2

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap513.19M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.91
Fwd PE N/A
P/S N/A
P/FCF 41.07
P/OCF 41.07
P/B 1.28
P/tB 1.28
EV/EBITDA N/A
EPS(TTM)0.79
EY7.75%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.25
FCFY2.43%
OCF(TTM)0.25
OCFY2.43%
SpS0
BVpS7.98
TBVpS7.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.84%
ROE 10.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 30.45%
Current Ratio 14.79
Quick Ratio 14.79
Altman-Z 19.58
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18482.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15550.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A